Skip to main content
Cellromax Science Co., Ltd. logo

Cellromax Science Co., Ltd. — Investor Relations & Filings

Ticker · 471820 ISIN · KR7471820001 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2025-04-03 Director's Dealing
Country KR South Korea
Listing KO 471820

About Cellromax Science Co., Ltd.

https://www.cellromax.kr/

Cellromax Science Co., Ltd. is a company specializing in the research, development, and manufacturing of health-related products. Its portfolio is centered on three key areas: health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company leverages scientific research and high-quality, naturally derived ingredients to create unique and effective products. Its development philosophy emphasizes optimized formulas and specialized prescriptions designed to support consumer health, skin vitality, and overall well-being.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure of insider trading or changes in share ownership by company directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS).
2025-04-03 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific execution of a treasury share disposal previously announced on March 13, 2025, for the purpose of employee stock compensation (RSU). Since the document reports the actual execution of a share transaction by the company involving its own shares, it falls under the category of 'Transaction in Own Shares'.
2025-04-03 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Cellromax Science. It details the company's share buyback activity through a trust contract with Shinyoung Securities. This type of filing, which reports the company's purchase of its own shares, falls under the 'Transaction in Own Shares' category.
2025-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for Cellromax Science. It details the outcomes of agenda items such as financial statement approval, dividend declarations, and the appointment of directors and auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of an outside director (사외이사). This type of corporate governance disclosure specifically pertains to changes in the board of directors, which falls under the 'Board/Management Information' category.
2025-03-28 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Cellromax Science' (주식회사 셀로맥스사이언스) for the fiscal year ending December 31, 2024. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report (AR) as it contains the results of the audit and the financial statements. FY 2024
2025-03-21 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.